SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹16,984 Cr | ₹19,906 Cr | ₹17,208 Cr | ₹16,146 Cr | ₹15,706 Cr |
What is the latest Total Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹16,984 Cr |
Mar2023 | ₹19,906 Cr |
Mar2022 | ₹17,208 Cr |
Mar2021 | ₹16,146 Cr |
Mar2020 | ₹15,706 Cr |
How is Total Current Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹16,984 Cr | -14.68 | |
Mar2023 | ₹19,906 Cr | 15.68 | |
Mar2022 | ₹17,208 Cr | 6.58 | |
Mar2021 | ₹16,146 Cr | 2.80 | |
Mar2020 | ₹15,706 Cr | - |
Compare Total Current Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹416,386.5 Cr | -2.8% | 7.6% | 8.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | -2.3% | 0.8% | 72.7% | Stock Analytics | |
CIPLA | ₹116,434.0 Cr | -5.4% | -1.5% | 0.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,474.0 Cr | -0.8% | 6.8% | 25.6% | Stock Analytics | |
MANKIND PHARMA | ₹99,974.0 Cr | 2.1% | 3.7% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,465.9 Cr | -5.5% | 1.6% | -5.1% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -2.8% |
7.6% |
8.4% |
SENSEX | 0.7% |
4% |
6.3% |
You may also like the below Video Courses